{"id":"https://openalex.org/W7225399299","doi":"https://doi.org/10.6084/m9.figshare.34938027","title":"A Biologically Optimized PEG-IFN-\u03b12 Variant Exhibits Potent Anti-HBV and Immunomodulatory Efficacy","display_name":"A Biologically Optimized PEG-IFN-\u03b12 Variant Exhibits Potent Anti-HBV and Immunomodulatory Efficacy","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225399299","doi":"https://doi.org/10.6084/m9.figshare.34938027"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.34938027","doi":"https://doi.org/10.6084/m9.figshare.34938027","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34938027","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.34938027","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093325509","display_name":"Asha Ashuo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Asha Ashuo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073519920","display_name":"Jianyu Ye","orcid":"https://orcid.org/0009-0009-2369-7369","observed_orcids":["https://orcid.org/0009-0009-2369-7369"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianyu Ye","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108992448","display_name":"Ruohan Jia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruohan Jia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161094571","display_name":"Yumeng Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yumeng Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161095566","display_name":"Yansong Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yansong Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161133283","display_name":"Zhong Fang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhong Fang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012219304","display_name":"Michael Zhiyan Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Zhiyan Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019106921","display_name":"Jieliang Chen","orcid":"https://orcid.org/0000-0002-9647-0239","observed_orcids":["https://orcid.org/0000-0002-9647-0239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jieliang Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5161081223","display_name":"Zhenghong Yuan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhenghong Yuan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha-2","display_name":"interferon alpha 2","score":0.6370000243186951},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9629999995231628},{"id":"https://openalex.org/keywords/hbv-replication-inhibition","display_name":"HBV replication inhibition","score":0.5830000042915344},{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.8080000281333923},{"id":"https://openalex.org/keywords/interferon-gamma-signaling","display_name":"interferon-gamma signaling","score":0.5929999947547913},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.7720000147819519},{"id":"https://openalex.org/keywords/m1-macrophage-polarization","display_name":"M1 macrophage polarization","score":0.8370000123977661},{"id":"https://openalex.org/keywords/cd8-t-cell-exhaustion","display_name":"CD8+ T cell exhaustion","score":0.9449999928474426},{"id":"https://openalex.org/keywords/antigen-presenting-cells","display_name":"antigen-presenting cells","score":0.8240000009536743},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.6869999766349792},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7139000296592712},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.57669997215271},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.49309998750686646},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.45660001039505005},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4309000074863434},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.4115000069141388},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4018000066280365},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39800000190734863},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3930000066757202},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3626999855041504},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3614000082015991},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35850000381469727},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3402999937534332},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3398999869823456},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.3228999972343445},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.3109000027179718},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3098999857902527},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.30809998512268066},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.30230000615119934},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.29820001125335693},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.28529998660087585},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.28519999980926514},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2831000089645386},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.27059999108314514},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.26919999718666077},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.2669999897480011},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.2554999887943268},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2506999969482422}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.34938027","doi":"https://doi.org/10.6084/m9.figshare.34938027","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34938027","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.34938027.v1","doi":"https://doi.org/10.6084/m9.figshare.34938027.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34938027.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.34938027","doi":"https://doi.org/10.6084/m9.figshare.34938027","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34938027","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3018993583","https://openalex.org/W3115186616","https://openalex.org/W2077060471","https://openalex.org/W2595248089","https://openalex.org/W2003831905","https://openalex.org/W2567073997","https://openalex.org/W7212290047","https://openalex.org/W4388943208","https://openalex.org/W1996544788","https://openalex.org/W7197047074"],"abstract_inverted_index":{"Human":[0],"interferon-alpha":[1],"(IFN-\u03b1)":[2],"includes":[3],"13":[4],"subtypes,":[5],"but":[6],"only":[7],"IFN-\u03b12":[8],"(a/b)":[9],"is":[10],"clinically":[11],"approved":[12],"for":[13,82,220],"chronic":[14],"hepatitis":[15],"B":[16,159],"(CHB)":[17],"therapy,":[18],"limited":[19],"by":[20,183],"adverse":[21],"effects":[22,64],"and":[23,75,93,109,131,158,172,178,203],"suboptimal":[24],"response":[25],"rates.":[26],"Previously,":[27],"we":[28,99],"identified":[29],"IFN-\u03b114":[30],"as":[31,215],"a":[32],"superior":[33],"anti-HBV":[34,63,201],"subtype":[35],"compared":[36],"to":[37,40,70,166],"IFN-\u03b12,":[38],"leading":[39],"the":[41,44,60],"engineering":[42],"of":[43,65,77,137,153,185],"IFN-\u03b12-EIFK":[45,66,104],"variant,":[46],"which":[47],"mimics":[48],"IFN-\u03b114's":[49],"enhanced":[50,150,217],"antiviral":[51],"activity":[52,202],"through":[53],"targeted":[54],"mutations":[55],"at":[56,118],"receptor-binding":[57],"sites.":[58],"However,":[59],"in":[61,128],"vivo":[62],"remained":[67],"unexplored":[68],"due":[69],"its":[71,213],"short":[72],"plasma":[73],"half-life":[74],"lack":[76],"immunocompetent":[78,89],"murine":[79],"systems":[80],"suitable":[81],"evaluating":[83],"human":[84],"IFN-\u03b1":[85],"activity.":[86],"Using":[87],"an":[88,186,216],"IFNAR-hEC":[90,142],"mouse":[91],"model":[92],"HBV-infected":[94],"human-liver":[95],"chimeric":[96],"mice":[97,143],"etc,":[98],"demonstrated":[100],"that":[101,145,197],"N-terminally":[102],"PEGylated":[103],"(PEG-IFN-\u03b12-EIFK)":[105],"suppressed":[106],"HBV":[107],"replication":[108],"antigen":[110],"expression":[111],"approximately":[112],"10-fold":[113],"more":[114],"effectively":[115],"than":[116,206],"PEG-IFN-\u03b12":[117,207],"equivalent":[119,209],"mass":[120,210],"doses,":[121],"while":[122],"concurrently":[123],"activating":[124],"IFN-\u03b3-like":[125],"signaling":[126],"pathways":[127],"both":[129],"hepatocytes":[130],"immune":[132,139],"cells.":[133,160],"Subsequent":[134],"single-cell":[135],"analysis":[136],"intrahepatic":[138],"cells":[140,156],"from":[141],"showed":[144],"PEG-IFN-\u03b12-EIFK":[146,163,198],"was":[147,164],"associated":[148],"with":[149],"antigen-presenting":[151],"capacity":[152],"macrophages,":[154],"dendritic":[155],"(DCs),":[157],"In":[161,192],"addition,":[162],"found":[165],"preferentially":[167],"promote":[168],"M1-like":[169],"macrophage":[170],"polarization,":[171],"modulate":[173],"PD-L1/PD-1":[174],"interactions":[175],"between":[176],"macrophages":[177],"CD8+":[179,188],"T":[180,189],"cells,":[181],"accompanied":[182],"attenuation":[184],"exhaustion-associated":[187],"cell":[190],"state.":[191],"conclusion,":[193],"this":[194],"study":[195],"demonstrates":[196],"exhibits":[199],"greater":[200],"immunomodulatory":[204],"potency":[205],"under":[208],"dosing,":[211],"supporting":[212],"potential":[214],"therapeutic":[218],"candidate":[219],"CHB.":[221]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}